The chemotherapy of leprosy.
D000818:Animals; D002991:Clofazimine / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004359:Drug Therapy, Combination; D006801:Humans; D007700:Kinetics; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy*; D051379:Mice; D009166:Mycobacterium leprae; D051381:Rats; D012294:Rifamycins / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013450:Sulfones / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use
D007917:Leprostatic Agents; D012294:Rifamycins; D013450:Sulfones; D002991:Clofazimine; D013828:Thioacetazone